BioSpace News Archive

Today, the U.S. Food and Drug Administration amended the emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 Vaccine, authorizing the use of a single booster dose for administration to individuals 5 through 11 years of age at least five months after completion of a primary series with the Pfizer-BioNTech COVID-19 Vaccine.

Rapid progress in preclinical and clinical research to improve outcomes of stem cell therapy and expand its application scope, and growing focus on advancing regenerative medicine are some other key factors expected to drive revenue growth of the market.

Immunization is a public health and development success storey that saves millions of lives each year. By bolstering the body’s natural defences, vaccines reduce the chances of developing a disease. Vaccination helps avoid over 20 life-threatening diseases, helping people of all ages to live longer, healthier lives. Vaccines save lives of 2-3 million people per year from diseases such as diphtheria, tetanus, pertussis, influenza, and measles.

VenoStent, Inc. announces that The Center for Devices and Radiological Health at the Food and Drug Administration has granted its novel technology, the SelfWrap® Bioabsorbable Perivascular Wrap, Breakthrough Device Designation.

Rising prevalence of neurological diseases such as Alzheimer’s disease, Parkinson’s disease, and brain tumors is one of the major factors supporting the global market revenue growth

Increasing demand for high quality food products, rapidly expanding global population, and ongoing research activities on plant genomics are some key factors expected to drive global market growth

Brain health supplements are made from natural substances or extracts from herbs or plants that essentially boost memory function, attention, focus, and alertness in healthy adults. They have also been proven to be highly effective in the management of sleep, depression, and anxiety.

Aquavit Pharmaceuticals, Inc. announced that it has appointed Senior Vice President Timothy Sherwood as Chief Operating Officer.

Increasing research & development activities in the field for innovating diagnosis procedures, is further expected to drive market revenue growth over the forecast period.

Increasing incidence of chronic orthopedic diseases such as rheumatoid arthritis, osteoarthritis, osteoarthritis, rising geriatric population, and increasing funds by public and private organizations are expected to drive global market growth